| |
Lean subjects (n = 33)
|
Obese subjects (n = 30)
|
|---|
|
HbA1c (%)
|
5.34 ± 0.41
|
5.78 ± 0.50*
|
|
Plasma glucose (mmol/l)
|
4.86 ± 0.48
|
5.35 ± 0.57*
|
|
Plasma insulin (pmol/l)
|
65.84 ± 32.14
|
105.33 ± 68.60*
|
|
M/FFM (μmol × kg-1 × min-1)
|
50.50 ± 14.64
|
39.37 ± 12.44*
|
|
Plasma TC (mmol/l)
|
4.43 ± 0.78
|
5.52 ± 1.08*
|
|
Plasma TG (mmol/l)
|
1.02 ± 0.52
|
1.64 ± 0.93*
|
|
Plasma HDL-C (mmol/l)
|
1.37 ± 0.32
|
1.23 ± 0.41
|
|
Plasma LDL-C (mmol/l)
|
2.59 ± 0.81
|
3.52 ± 0.96*
|
|
Plasma NEFA (mmol/l)
|
0.347 ± 0.116
|
0.504 ± 0.155*
|
|
Plasma TNFα (pg/ml)
|
4.89 ± 1.53
|
5.22 ± 2.69
|
|
Plasma sTNFR1 (ng/ml)
|
1.94 ± 0.37
|
2.36 ± 0.44*
|
|
Plasma sTNFR2 (ng/ml)
|
4.12 ± 0.79
|
4.74 ± 1.20*
|
- HbA1c, glycated hemoglobin; M/FFM, whole-body glucose uptake normalized per kg of fat-free mass; TC, total cholesterol; TG, triglycerides; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol; NEFA, non-esterified fatty acids; TNFα, tumor necrosis factor α; sTNFR1, soluble TNFα receptor 1; sTNFR2, soluble TNFα receptor 2.
- *p < 0.05 in obese vs lean subjects.
